Statistics

Total Visits

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial79

Select a period of time:

Number of views in the range

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial15

Views

Views
December 20251
January 20260
February 20260
March 20261
April 20263
May 20267
June 20263
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Argentina1
Costa Rica1
Netherlands1
Portugal1
Singapore1
 

Top cities views

Views
Ashburn1
Brooklyn1
Buffalo1
Gilbert1
Grants Pass1
Groningen1
Milwaukee1
Porto1
Pérez Zeledón1
Villa Allende1